These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 1719714

  • 21. Neutralizing and non-neutralizing monoclonal antibodies to the E2 glycoprotein of Semliki Forest virus can protect mice from lethal encephalitis.
    Boere WA, Benaissa-Trouw BJ, Harmsen M, Kraaijeveld CA, Snippe H.
    J Gen Virol; 1983 Jun; 64 (Pt 6)():1405-8. PubMed ID: 6854274
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Comprehensive evaluation of the adenovirus/alphavirus-replicon chimeric vector-based vaccine rAdV-SFV-E2 against classical swine fever.
    Sun Y, Tian DY, Li S, Meng QL, Zhao BB, Li Y, Li D, Ling LJ, Liao YJ, Qiu HJ.
    Vaccine; 2013 Jan 07; 31(3):538-44. PubMed ID: 23153441
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Recombinant Semliki Forest virus particles expressing louping ill virus antigens induce a better protective response than plasmid-based DNA vaccines or an inactivated whole particle vaccine.
    Fleeton MN, Liljeström P, Sheahan BJ, Atkins GJ.
    J Gen Virol; 2000 Mar 07; 81(Pt 3):749-58. PubMed ID: 10675413
    [Abstract] [Full Text] [Related]

  • 30. T-cell hybridomas recognizing the envelope proteins of Semliki forest virus: their sensitivity to endo/lysosomal protease and the antigenicity.
    Watari E, Yokomuro K.
    Jpn J Med Sci Biol; 1992 Jun 07; 45(3):113-25. PubMed ID: 1283995
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Generation of cytotoxic and humoral immune responses by nonreplicative recombinant Semliki Forest virus.
    Zhou X, Berglund P, Zhao H, Liljeström P, Jondal M.
    Proc Natl Acad Sci U S A; 1995 Mar 28; 92(7):3009-13. PubMed ID: 7708765
    [Abstract] [Full Text] [Related]

  • 36. The significance of carbohydrate trimming for the antigenicity of the Semliki Forest virus glycoprotein E2.
    Kaluza G, Repges S, McDowell W.
    Virology; 1990 Jun 28; 176(2):369-78. PubMed ID: 1693245
    [Abstract] [Full Text] [Related]

  • 37. Use of conventional or replicating nucleic acid-based vaccines and recombinant Semliki forest virus-derived particles for the induction of immune responses against hepatitis C virus core and E2 antigens.
    Vidalin O, Fournillier A, Renard N, Chen M, Depla E, Boucreux D, Brinster C, Baumert T, Nakano I, Fukuda Y, Liljeström P, Trépo C, Inchauspé G.
    Virology; 2000 Oct 25; 276(2):259-70. PubMed ID: 11040118
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Virus-Like Vesicle-Based Therapeutic Vaccine Vectors for Chronic Hepatitis B Virus Infection.
    Reynolds TD, Buonocore L, Rose NF, Rose JK, Robek MD.
    J Virol; 2015 Oct 25; 89(20):10407-15. PubMed ID: 26246574
    [Abstract] [Full Text] [Related]

  • 40. Structural plasticity of the Semliki Forest virus glycome upon interspecies transmission.
    Crispin M, Harvey DJ, Bitto D, Bonomelli C, Edgeworth M, Scrivens JH, Huiskonen JT, Bowden TA.
    J Proteome Res; 2014 Mar 07; 13(3):1702-12. PubMed ID: 24467287
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.